Related Experiment Videos
Abstract:
Following the immunosuppressive treatment, applied after renal transplantations, infectious diseases are seen more frequently. Inspite of more frequency of bacterial infections, they can usually be controlled because of their easier diagnosis and treatment. However the mycotic diseases are usually fatal because of their easier diagnosis and treatment. However the mycotic diseases are usually fatal because of the difficulty in their diagnosis and treatment. The immunosuppressive treatment agents are cytotoxic medicines, codticosteroids, antilymphocytic sera (or antithymocytic sera) and radiation. The mycotic infections, more often encountered are candidiasis, aspergillosis, nocardiosis, cryptococcosis and phycomycosis. There are certain medicines used today in the treatment of deep mycotic infections. These are amphotericine B, 5 fluorocytosine and imidazol derivatives.
Insights
Post-renal transplant immunosuppression increases infectious disease risk, particularly fatal fungal infections. Early diagnosis and targeted treatments like amphotericin B are crucial for managing these severe mycotic diseases.
Area of Science:
- Nephrology
- Infectious Diseases
- Mycology
Background:
- Immunosuppressive therapy after renal transplantation increases patient susceptibility to infections.
- While bacterial infections are common, they are generally manageable due to easier diagnosis and treatment.
- Fungal (mycotic) infections pose a significant threat, often proving fatal due to diagnostic and therapeutic challenges.
Purpose of the Study:
- To highlight the increased incidence of infectious diseases post-renal transplantation.
- To differentiate the challenges in managing bacterial versus fungal infections in this patient population.
- To review common mycotic infections and current therapeutic agents.
Main Methods:
- Review of clinical literature on infections following renal transplantation.
- Analysis of common immunosuppressive agents and their role in infection susceptibility.
- Identification of prevalent fungal pathogens and their treatment modalities.
Main Results:
- Immunosuppressive agents include cytotoxic drugs, corticosteroids, antilymphocytic sera, and radiation.
- Commonly encountered mycotic infections include candidiasis, aspergillosis, nocardiosis, cryptococcosis, and phycomycosis.
- Current treatments for deep mycotic infections involve amphotericin B, 5-fluorocytosine, and imidazole derivatives.
Conclusions:
- Fungal infections represent a critical and often fatal complication of immunosuppression after renal transplantation.
- Effective management requires prompt diagnosis and appropriate antifungal therapy.
- Further research into novel antifungal strategies is warranted to improve outcomes.